Clorox Files Q2 2025 10-Q
Ticker: CLX · Form: 10-Q · Filed: Feb 3, 2025 · CIK: 21076
| Field | Detail |
|---|---|
| Company | Clorox Co /De/ (CLX) |
| Form Type | 10-Q |
| Filed Date | Feb 3, 2025 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
Related Tickers: CLX
TL;DR
CLX Q2 2025 10-Q filed. Financials updated.
AI Summary
Clorox Company reported its Q2 2025 results for the period ending December 31, 2024. The company's fiscal year ends on June 30th. Key financial data and business segment information are included in this filing.
Why It Matters
This filing provides investors with an update on Clorox's financial performance and operational status for the second quarter of fiscal year 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Players & Entities
- CLOROX CO /DE/ (company) — Filer
- 20241231 (date) — Period of Report
- 20250203 (date) — Filing Date
- 0000021076 (company) — Central Index Key
- 2842 (industry_code) — Standard Industrial Classification
- 310595760 (tax_id) — IRS Number
- DE (state) — State of Incorporation
- 0630 (date) — Fiscal Year End
- 1221 BROADWAY (address) — Business Street 1
- OAKLAND (city) — Business City
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20241231, indicating the period ending December 31, 2024.
When was this 10-Q filing submitted to the SEC?
The filing was submitted on 20250203.
What is Clorox's fiscal year end date?
Clorox's fiscal year ends on 0630.
What is Clorox's Standard Industrial Classification code?
Clorox's SIC code is 2842, for Specialty Cleaning, Polishing and Sanitation Preparations.
What is the business address of The Clorox Company?
The business address is 1221 Broadway, Oakland, CA 94612-1888.
Filing Stats: 4,598 words · 18 min read · ~15 pages · Grade level 17 · Accepted 2025-02-03 16:45:16
Key Financial Figures
- $1.00 — nge on which registered Common Stock - $1.00 par value CLX New York Stock Exchange
Filing Documents
- clx-20241231.htm (10-Q) — 1509KB
- clxq2fy25ex311ceocertifica.htm (EX-31.1) — 9KB
- clxq2fy25ex312cfocertifica.htm (EX-31.2) — 9KB
- clxq2fy25ex32ceocfocertifi.htm (EX-32) — 6KB
- clx-20241231_g1.jpg (GRAPHIC) — 15KB
- 0000021076-25-000013.txt ( ) — 8311KB
- clx-20241231.xsd (EX-101.SCH) — 43KB
- clx-20241231_cal.xml (EX-101.CAL) — 82KB
- clx-20241231_def.xml (EX-101.DEF) — 211KB
- clx-20241231_lab.xml (EX-101.LAB) — 564KB
- clx-20241231_pre.xml (EX-101.PRE) — 408KB
- clx-20241231_htm.xml (XML) — 1695KB
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION 3
Financial Statements
Item 1. Financial Statements 3 Condensed Consolidated Statements of Earnings and Comprehensive Income 3 Condensed Consolidated Balance Sheets 4 Condensed Consolidated Statements of Cash Flows 5 Notes to Condensed Consolidated Financial Statements 6
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 21
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 35
Controls and Procedures
Item 4. Controls and Procedures 35
- OTHER INFORMATION
PART II - OTHER INFORMATION 36
A. Risk Factors
Item 1.A. Risk Factors 36
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 36
Other Information
Item 5. Other Information 36
Exhibits
Item 6. Exhibits 37 2
– FINANCIAL INFORMATION
PART I – FINANCIAL INFORMATION
Financial Statements
Item 1. Financial Statements The Clorox Company Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) (Dollars in millions, except per share data) Three months ended Six months ended 12/31/2024 12/31/2023 12/31/2024 12/31/2023 Net sales $ 1,686 $ 1,990 $ 3,448 $ 3,376 Cost of products sold 948 1,124 1,903 1,978 Gross profit 738 866 1,545 1,398 Selling and administrative expenses 280 322 561 598 Advertising costs 191 186 392 351 Research and development costs 31 32 62 61 Loss on divestiture — — 118 — Pension settlement charge — 171 — 171 Interest expense 22 26 43 47 Other (income) expense, net ( 23 ) ( 7 ) ( 45 ) 5 Earnings before income taxes 237 136 414 165 Income tax expense 43 40 117 44 Net earnings 194 96 297 121 Less: Net earnings attributable to noncontrolling interests 1 3 5 6 Net earnings attributable to Clorox $ 193 $ 93 $ 292 $ 115 Net earnings per share attributable to Clorox Basic net earnings per share $ 1.55 $ 0.75 $ 2.36 $ 0.93 Diluted net earnings per share $ 1.54 $ 0.75 $ 2.34 $ 0.92 Weighted average shares outstanding (in thousands) Basic 123,766 124,176 123,781 124,075 Diluted 124,662 124,620 124,669 124,635 Comprehensive income $ 160 $ 231 $ 271 $ 255 Less: Total comprehensive income attributable to noncontrolling interests 1 3 5 6 Total comprehensive income attributable to Clorox $ 159 $ 228 $ 266 $ 249 See Notes to Condensed Consolidated Financial Statements (Unaudited) 3 The Clorox Company Condensed Consolidated Balance Sheets (Dollars in millions, except per share data) 12/31/2024 6/30/2024 (Unaudited) ASSETS Current assets Cash and cash equivalents $ 290 $ 202 Receivables, net 603 695 Inventories, net 592 637 Prepaid expenses and other current assets 147 88 Total current assets 1,632 1,622 Property, plant and equipment, net of accumulated depreciation and amortization of $ 2,831 and $ 2,821 , respectively 1,242 1,315 Operating lease right-of-use asset